Tuesday - August 25, 2026
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
August 25, 2026
WASHINGTON, Aug. 25 [Category: BizLaw/Legal] -- WilmerHale, a law firm, posted the following news:

* * *

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

*

WilmerHale advised the underwriters in the public offering of 16,203,500 shares of common stock of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), at a public offering price of $35.50 per share, including the full exercise of the u . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products